Vimentin- immunoreactivity in astrocytes, macrophages and microglia becomes intensely positive in areas of brain affected by Alzheimer’s disease, multiple sclerosis, Pick’s disease, amyotrophic lateral sclerosis and cerebral infarction patients. Here, VIM is linked to early-onset autosomal dominant Alzheimer disease.